Your browser doesn't support javascript.
loading
GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses.
Klugar, Miloslav; Lotfi, Tamara; Darzi, Andrea J; Reinap, Marge; Klugarová, Jitka; Kantorová, Lucia; Xia, Jun; Brignardello-Petersen, Romina; Pokorná, Andrea; Hazlewood, Glen; Munn, Zachary; Morgan, Rebecca L; Toews, Ingrid; Neumann, Ignacio; Bhatarasakoon, Patraporn; Stein, Airton Tetelbom; McCaul, Michael; Mathioudakis, Alexander G; D'Anci, Kristen E; Leontiadis, Grigorios I; Naude, Celeste; Vasanthan, Lenny T; Khabsa, Joanne; Bala, Malgorzata M; Mustafa, Reem; DiValerio Gibbs, Karen; Nieuwlaat, Robby; Santesso, Nancy; Pieper, Dawid; Mokrane, Saphia; Soghier, Israa; Lertwatthanawilat, Wanchai; Wiercioch, Wojtek; Sultan, Shahnaz; Rozmarinová, Jana; Drapacová, Pavla; Song, Yang; Amer, Marwa; Amer, Yasser S; Sayfi, Shahab; Verstijnen, Ilse M; Shin, Ein-Soon; Saz-Parkinson, Zuleika; Pottie, Kevin; Ruspi, Alessandra; Marusic, Ana; Saif-Ur-Rahman, K M; Rojas, Maria X; Akl, Elie A; Schünemann, Holger J.
Afiliación
  • Klugar M; Cochrane Czech Republic, Czech CEBHC: JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic; Center of Evidence-based Education and Arts Therapies: A JBI Affiliated Group, Faculty of Education, Palacký University O
  • Lotfi T; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada & McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster Univers
  • Darzi AJ; Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Ontario, Canada; Department of Anesthesia, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Reinap M; Division of Country Health Policies and Systems, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
  • Klugarová J; Cochrane Czech Republic, Czech CEBHC: JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic; Center of Evidence-based Education and Arts Therapies: A JBI Affiliated Group, Faculty of Education, Palacký University O
  • Kantorová L; Cochrane Czech Republic, Czech CEBHC: JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Xia J; Agency for Clinical Practice Guideline, Korean Academy of Medical Sciences, Seoul, South Korea; Division of Lifespan and Population Health, The University of Nottingham, Nottingham, UK.
  • Brignardello-Petersen R; Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Ontario, Canada.
  • Pokorná A; Cochrane Czech Republic, Czech CEBHC: JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic; Department of Health Sciences, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Hazlewood G; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Munn Z; Health Evidence Synthesis, Recommendations and Impact, School of Public Health, The University of Adelaide, Adelaide, South Australia, Australia.
  • Morgan RL; Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Ontario, Canada; School of Medicine, Case Western Reserve University, Cleveland, OH USA.
  • Toews I; Institute for Evidence in Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Neumann I; Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Ontario, Canada; School of Medicine, Universidad San Sebastian, Santiago, Chile.
  • Bhatarasakoon P; Thailand Center for Evidence-Based Health Care, Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand.
  • Stein AT; Department of Public Health, Universidade Federal de Ciências da Saúde de Porto Alegre (Ufcspa), Porto Alegre, Brazil.
  • McCaul M; Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch Univeristy, Cape Town, South Africa.
  • Mathioudakis AG; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, UK; North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • D'Anci KE; Sigma Health Consulting, LLC, McLean, VA, USA.
  • Leontiadis GI; Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Ontario, Canada.
  • Naude C; Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch Univeristy, Cape Town, South Africa.
  • Vasanthan LT; Department of Physical Medicine and Rehabilitation, Christian Medical College, Vellore, India.
  • Khabsa J; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Bala MM; Chair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Krakow, Poland; Krakow GRADE Centre, Krakow, Poland.
  • Mustafa R; Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Ontario, Canada; Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, MO, USA.
  • DiValerio Gibbs K; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
  • Nieuwlaat R; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada & McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster Univers
  • Santesso N; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada & McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster Univers
  • Pieper D; Faculty of Health Sciences Brandenburg, Brandenburg Medical School (Theodor Fontane), Institute for Health Services and Health System Research, Rüdersdorf, Germany; Center for Health Services Research, Brandenburg Medical School (Theodor Fontane), Rüdersdorf, Germany.
  • Mokrane S; Department of Primary Care, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium; Working group Development of Primary Care Guidelines, Antwerpen, Belgium.
  • Soghier I; Department of Medicine, Massachusetts General Brigham/Salem Hospital, Boston, MA, USA.
  • Lertwatthanawilat W; Thailand Center for Evidence-Based Health Care, Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand.
  • Wiercioch W; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada & McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster Univers
  • Sultan S; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota, Minneapolis, MN, USA.
  • Rozmarinová J; Cochrane Czech Republic, Czech CEBHC: JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
  • Drapacová P; Cochrane Czech Republic, Czech CEBHC: JBI Centre of Excellence, Czech GRADE Network, Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
  • Song Y; Iberoamerican Cochrane Centre, Biomedical Research, Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
  • Amer M; Medical/Critical Pharmacy Division, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; College of Medicine and Pharmacy, Alfaisal University, Riyadh, Saudi Arabia.
  • Amer YS; Pediatrics Department, Quality Management Department, King Saud University Medical City, Research Chair for Evidence-Based Healthcare and Knowledge Translation, King Saud University, Riyadh, Saudi Arabia; Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeir
  • Sayfi S; World Health Organization Collaborating Center for Infectious Diseases, Research Methods and Recommendations, Michael G. DeGroote Cochrane Canada & McMaster GRADE Centres, McMaster University, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence and Impact, McMaster Univers
  • Verstijnen IM; Research and Development, National Health Care Institute, Zorginstituut, The Netherlands.
  • Shin ES; Department of Preventive Medicine and Public Health, School of Medicine, Ajou University, Suwon, South Korea.
  • Saz-Parkinson Z; European Research Executive Agency, European Commission, Brussels, Belgium.
  • Pottie K; Departments of Family Medicine and Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
  • Ruspi A; Clinical Epidemiology and Research Center (CERC), Humanitas University & Humanitas Research Hospital, Via Rita Levi Montalcini 4 - 20090 Pieve Emanuele, Milano, Italy; Physiotherapy Unit, Humanitas Clinical and Research Center - IRCCS, Rozzano, Milan, Italy.
  • Marusic A; Center for Evidence-based Medicine, Medicinski fakultet Sveucilista u Splitu, University of Split School of Medicine, Split, Croatia.
  • Saif-Ur-Rahman KM; College of Medicine, Nursing, and Health Sciences, University Galway, Galway, Ireland; Evidence Synthesis Ireland and Cochrane Ireland University of Galway, Galway, Ireland.
  • Rojas MX; Department of Clinical Epidemiology and Public Health, The Sant Pau Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain.
  • Akl EA; Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Ontario, Canada; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Schünemann HJ; Department of Health Research Methods, Evidence and Impact, McMaster University, 1280 Main Street West, Hamilton, L8S 4L8, Ontario, Canada; Clinical Epidemiology and Research Center (CERC), Humanitas University & Humanitas Research Hospital, Via Rita Levi Montalcini 4 - 20090 Pieve Emanuele, Mil
J Clin Epidemiol ; 174: 111494, 2024 Aug 06.
Article en En | MEDLINE | ID: mdl-39117011
ABSTRACT
BACKGROUND AND

OBJECTIVE:

The Grading of Recommendations, Assessment, Development and Evaluations (GRADE)-ADOLOPMENT methodology has been widely used to adopt, adapt, or de novo develop recommendations from existing or new guideline and evidence synthesis efforts. The objective of this guidance is to refine the operationalization for applying GRADE-ADOLOPMENT.

METHODS:

Through iterative discussions, online meetings, and email communications, the GRADE-ADOLOPMENT project group drafted the updated guidance. We then conducted a review of handbooks of guideline-producing organizations, and a scoping review of published and planned adolopment guideline projects. The lead authors refined the existing approach based on the scoping review findings and feedback from members of the GRADE working group. We presented the revised approach to the group in November 2022 (approximately 115 people), in May 2023 (approximately 100 people), and twice in September 2023 (approximately 60 and 90 people) for approval.

RESULTS:

This GRADE guidance shows how to effectively and efficiently contextualize recommendations using the GRADE-ADOLOPMENT approach by doing the following (1) showcasing alternative pathways for starting an adolopment effort; (2) elaborating on the different essential steps of this approach, such as building on existing evidence-to-decision (EtDs), when available or developing new EtDs, if necessary; and (3) providing examples from adolopment case studies to facilitate the application of the approach. We demonstrate how to use contextual evidence to make judgments about EtD criteria, and highlight the importance of making the resulting EtDs available to facilitate adolopment efforts by others.

CONCLUSION:

This updated GRADE guidance further operationalizes the application of GRADE-ADOLOPMENT based on over 6 years of experience. It serves to support uptake and application by end users interested in contextualizing recommendations to a local setting or specific reality in a short period of time or with limited resources.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Epidemiol Asunto de la revista: EPIDEMIOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Epidemiol Asunto de la revista: EPIDEMIOLOGIA Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos